Purchase Order W81K0022P0180
Award Date
10/1/22
Potential Completion Date
9/30/27
Potential Value
$228K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Immucor Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
El Paso, TX 79920, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Air Education and Training Command, a defense agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The contract is for the provision of blood typing reagents, with a ceiling value of $121,323.95 and a completion date of September 30, 2020. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare agencies, including the Department of Veterans...
This contract award to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, is for the delivery of blood reagents, test kits, and diagnostic products to support the testing programs and healthcare services of the Defense Health Agency (DHA). The $260,536.03 firm fixed-price delivery order was issued under Immucor's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and test kits. The award does not have a...
The Department of the Air Force Air Education and Training Command awarded a firm-fixed price delivery order contract worth $122,698.05 to Immucor Inc., a for-profit manufacturer of goods, for the provision of blood typing reagents. Immucor has extensive experience providing specialized reagents, blood analyzers, testing equipment, and related consumables to enable blood typing, compatibility testing, antibody screening, and critical blood banking operations for federal health networks and...
This is a firm-fixed price supply contract awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The contract, valued at $1,016,206.99, is for the delivery of consumable reagents used for blood typing, antibody screening, and identifying compatible blood products for transfusion. The contract has a base period of one year from October 1, 2023 to September 30, 2024, with four one-year option periods. The original...
Immucor Inc. has been awarded a $59,188.35 delivery order against its Federal Supply Schedule contract for blood bank reagents. The contract calls for Immucor to provide blood typing, compatibility testing, antibody screening, and other critical reagents to support the blood banking operations of the Defense Health Agency. Performance will take place in Norcross, Georgia through September 30, 2023. As the prime contractor for this delivery order, Immucor will leverage its expertise in...
This is a federal contract award to Immucor Inc., a leading provider of automated in vitro diagnostics, reagents, and test kits for blood transfusion and transplantation compatibility testing. The contract, awarded by the Defense Health Agency, is for the delivery of blood bank reagents under a firm fixed-price, indefinite delivery contract with a ceiling value of $242,001.84 and a period of performance through September 30, 2027. The contract was awarded on September 18, 2024 and is not...
Immucor Inc. has been awarded a $30,219.52 firm fixed price delivery order by the Defense Health Agency to provide blood bank reagents for Korea from October 1, 2023 through September 30, 2024. The award utilizes Immucor's multiple award schedule contract vehicle for laboratory supplies to facilitate the recurring purchase of essential blood banking items on an as-needed basis in support of the Agency's healthcare services and testing programs. As a leading provider of automated...
This federal contract award is for the delivery of blood bank reagents to support the operations of the Defense Health Agency (DHA) from June 13, 2024 to September 30, 2024. The $35,616.26 firm fixed price delivery order was awarded to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products and blood banking supplies. Immucor has previously held multiple award schedule contracts and other federal awards with agencies such as the Department of Veterans Affairs and Indian Health...
This is a firm fixed-price delivery order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical equipment, reagents, and supplies. The $59,572.95 contract is for blood bank reagents and is issued under Immucor's General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. This is not a set-aside contract. The contract has an ultimate completion date of October 1, 2028. Immucor holds several...
This federal contract award, N6809622P0004, was issued by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of goods, for the provision of IMMUCOR REAGENTS. The contract is a Firm Fixed Price Purchase Order with a ceiling value of $80,569.98 and a completion date of September 27, 2022. No set-aside was used for this award. Immucor Inc. is a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing....